SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

Search

Eurofins Scientific SE

Geschlossen

69.98 1.13

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

68.92

Max

70.58

Schlüsselkennzahlen

By Trading Economics

Einkommen

105M

228M

Verkäufe

1.9B

3.7B

KGV

Branchendurchschnitt

25.451

76.004

EPS

1.221

Dividendenrendite

1.12

Gewinnspanne

6.2

Angestellte

65,694

EBITDA

285M

693M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+11.39% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.12%

3.34%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.1B

11B

Vorheriger Eröffnungskurs

68.85

Vorheriger Schlusskurs

69.98

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Eurofins Scientific SE Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Apr. 2026, 20:26 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17. Apr. 2026, 18:15 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17. Apr. 2026, 22:58 UTC

Ergebnisse

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17. Apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17. Apr. 2026, 20:52 UTC

Ergebnisse

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17. Apr. 2026, 20:50 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

17. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Apr. 2026, 20:29 UTC

Ergebnisse

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15B

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17. Apr. 2026, 19:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17. Apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17. Apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17. Apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17. Apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17. Apr. 2026, 18:57 UTC

Wichtige Nachrichtenereignisse

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB 2026 Rev Guidance Unchanged

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17. Apr. 2026, 18:14 UTC

Market Talk
Wichtige Nachrichtenereignisse

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17. Apr. 2026, 17:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17. Apr. 2026, 17:26 UTC

Market Talk
Ergebnisse

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Peer-Vergleich

Kursveränderung

Eurofins Scientific SE Prognose

Kursziel

By TipRanks

11.39% Vorteil

12-Monats-Prognose

Durchschnitt 77.35 EUR  11.39%

Hoch 81 EUR

Tief 73.7 EUR

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Eurofins Scientific SE – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

54.22 / 56.82Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat